Separate names with a comma.
https://news.alphastreet.com/benefiting-from-tax-gains-valeant-pharma-swings-to-profit-in-q4/ The company now forecasts full year revenues below...
When providing the outlook for 2018, Saunders said that Allergan faces LOE losses in 2018. But still it has got good long-term prospects. Saunders...
After raising the quarterly dividend recently, Lilly has provided outlook for 2018 and expects recently launched products to drive revenue. Dave...
Cardinal Health (CAH) earnings for the first quarter of 2018 are hurt by restructuring costs from regaining direct distribution of...
Lower costs and expenses aid in a jump in 3Q17 earnings of Baxter. The company posted net income of $251MM or $0.45 per share, on sales of...
$VRTX Vertex's cystic fibrosis portfolio progression has led the company to increase its guidance of combined R&D and SG&A for the full year 2017.
